Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Peripheral Endovascular Intervention: later-stage trial registry

1 of 1 indexed Peripheral Endovascular Intervention trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Peripheral Endovascular Intervention: 1 US clinical trial tracked, 1 recruiting.

Peripheral Endovascular Intervention is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Duke University, running 1 of these trials.

Enrollment posture brief

Registry condition peripheral-endovascular-intervention

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Peripheral Endovascular (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Peripheral Endovascular Intervention

Peripheral Endovascular Intervention lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peripheral Endovascular Intervention on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peripheral Endovascular Intervention is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Duke University 1 trials

Named interventions

Most-linked intervention names on Peripheral Endovascular Intervention records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Normal Saline (Placebo) Drug
1 trials
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL Drug
1 trials

US sites by state

Facility locations filed on Peripheral Endovascular Intervention trials. A trial with sites in several states counts in each.

Florida 1 trials
Connecticut 1 trials
California 1 trials
Arkansas 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peripheral Endovascular Intervention page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Peripheral Endovascular Intervention trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Duke University sponsors the most Peripheral Endovascular Intervention trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Endovascular Intervention condition card totals 1 registered trials; most-linked intervention Normal Saline (Placebo); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.